NO20005556L - PTH 2 reseptor-selektive forbindelser - Google Patents

PTH 2 reseptor-selektive forbindelser

Info

Publication number
NO20005556L
NO20005556L NO20005556A NO20005556A NO20005556L NO 20005556 L NO20005556 L NO 20005556L NO 20005556 A NO20005556 A NO 20005556A NO 20005556 A NO20005556 A NO 20005556A NO 20005556 L NO20005556 L NO 20005556L
Authority
NO
Norway
Prior art keywords
pth
abnormal
selective compounds
receptor selective
functions
Prior art date
Application number
NO20005556A
Other languages
English (en)
Other versions
NO20005556D0 (no
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Beth Israel Hospital filed Critical Sod Conseils Rech Applic
Publication of NO20005556D0 publication Critical patent/NO20005556D0/no
Publication of NO20005556L publication Critical patent/NO20005556L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet en serie PTH og PTHrP analoger som selektivt blir bundet til PTH2 reseptorer og derfor kan være nyttige for behandling av unormale CNS funksjoner, unormale bukspyttkjertelfunksjoner, divergens fra normal mineralmetabolisme og homeostase, infertilitet hos menn, regulering av unormalt blodtrykk og hypothalmisk sykdom.
NO20005556A 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser NO20005556L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05
PCT/US1999/009521 WO1999057139A2 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Publications (2)

Publication Number Publication Date
NO20005556D0 NO20005556D0 (no) 2000-11-03
NO20005556L true NO20005556L (no) 2001-01-03

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005556A NO20005556L (no) 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser

Country Status (12)

Country Link
US (2) US7531621B1 (no)
EP (1) EP1075491B1 (no)
JP (1) JP4460157B2 (no)
AT (1) ATE392431T1 (no)
AU (1) AU3673699A (no)
CA (1) CA2327509A1 (no)
DE (1) DE69938548T2 (no)
ES (1) ES2302374T3 (no)
HU (1) HUP0300891A2 (no)
NO (1) NO20005556L (no)
PL (1) PL344645A1 (no)
WO (1) WO1999057139A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713294A (pt) 1996-09-26 2000-10-17 Chugai Pharmaceutical Co Ltd "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
KR100508338B1 (ko) 1997-05-15 2005-08-17 츄가이 세이야꾸 가부시키가이샤 악액질 치료제
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
EP1987842A1 (en) 2000-04-28 2008-11-05 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitor
AU2001292905A1 (en) * 2000-09-19 2002-04-02 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
JP5200027B2 (ja) 2006-10-13 2013-05-15 イーライ リリー アンド カンパニー Ｐｔｈ受容体モジュレーターとしてのペグ化ｐｔｈおよびその使用
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
RU2604809C2 (ru) 2010-05-13 2016-12-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги паратиреоидного гормона и их применение

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
DE68921665T2 (de) 1988-05-09 1995-09-21 Merck & Co Inc Hemmer vom flüssigen kalziumerhöhenden Faktor.
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1992011286A1 (en) * 1990-12-21 1992-07-09 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
ES2248853T3 (es) 1996-07-31 2006-03-16 The General Hospital Corporation Nuevos analogos del peptido relacionado con la hormona paratiroidea.

Also Published As

Publication number Publication date
DE69938548T2 (de) 2009-06-18
EP1075491B1 (en) 2008-04-16
ES2302374T3 (es) 2008-07-01
JP2002513801A (ja) 2002-05-14
US7531621B1 (en) 2009-05-12
CA2327509A1 (en) 1999-11-11
US20090226477A1 (en) 2009-09-10
HUP0300891A2 (hu) 2003-07-28
EP1075491A2 (en) 2001-02-14
WO1999057139A2 (en) 1999-11-11
DE69938548D1 (de) 2008-05-29
JP4460157B2 (ja) 2010-05-12
NO20005556D0 (no) 2000-11-03
WO1999057139A3 (en) 2000-02-03
AU3673699A (en) 1999-11-23
PL344645A1 (en) 2001-11-19
ATE392431T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
NO20005556L (no) PTH 2 reseptor-selektive forbindelser
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
MX9705383A (es) Compuesto que tienen efectos sobre los sistemas relacionados con la serotonina.
WO2000004862A3 (en) Bioenhanced formulations comprising eprosartan in oral solid dosage form
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
BG110227A (en) USE OF MODULATORS OF THE GLUCOCORTICOID RECEPTOR
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
TW200407305A (en) Novel compounds
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
SE0201448D0 (sv) Method for reducing methane production emanating from the digestive activites of an animal
MX360148B (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos.
DK1187537T3 (da) Fremgangsmåde og sammensætning til forögelse af mælkeproduktionen
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
DK1140031T3 (da) Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
ID27771A (id) Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu
WO1999029308A3 (de) Methode zur bekämpfung der fettleibigkeit
NO20014961L (no) Integrin-reseptor-ligander
NO974256D0 (no) Anvendelse av anti-östrogener som befruktningshindrende midler for menn
HK1029025A1 (en) Compressed chloramine-t tablets and method for the production thereof
HK1055059A2 (en) 5-SUBSTITUTED 7,9-DIFLUORO-5H-CHROMENO[3,4-f]QUINOLINE COMPOUNDS AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
IS5142A (is) Kínoxalíndíón

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application